Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparison of Sacubitril/Valsartan Versus Valsartan on the Outcome of Heart Failure With Improved Ejection Fraction: a Pilot Study

NCT04803175 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04803175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparison of Sacubitril/Valsartan Versus Valsartan on the Outcome of Heart Failure With Improved Ejection Fraction: a Pilot Study
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 16, 2021
Completion date
February 28, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, systolic